Audio Clinical Professionals

Wernicke Encephalopathy and Myeloma-Associated CIDP

Reviews Wernicke encephalopathy risk in cancer and the CIDP-like neuropathy seen with multiple myeloma.

Duration

00:03:39

File size

2.08 MB

Practitioner-Guided Note

Use thiamine risk and the CIDP-like neuropathy clue to avoid missing two treatable complications in oncology care. The practical goal is to start the right therapy early instead of attributing everything to chemotherapy alone.

Key Takeaways

Cancer-related Wernicke encephalopathy reflects thiamine depletion from malnutrition and emetogenic therapy; The classic triad is ophthalmoparesis, ataxia, and confusion; Multiple myeloma can cause a CIDP-like demyelinating neuropathy; Autoimmune encephalitis is often treated with steroids, IVIG, or plasmapheresis; Rituximab and cyclophosphamide are common second-line options